Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characteristic findings of skeletal muscle MRI in caveolinopathies.
Ishiguro K, Nakayama T, Yoshioka M, Murakami T, Kajino S, Shichiji M, Sato T, Hino-Fukuyo N, Kuru S, Osawa M, Nagata S, Okubo M, Murakami N, Hayashi YK, Nishino I, Ishigaki K. Ishiguro K, et al. Among authors: shichiji m. Neuromuscul Disord. 2018 Oct;28(10):857-862. doi: 10.1016/j.nmd.2018.07.010. Epub 2018 Jul 31. Neuromuscul Disord. 2018. PMID: 30174172
CDKL5 alterations lead to early epileptic encephalopathy in both genders.
Liang JS, Shimojima K, Takayama R, Natsume J, Shichiji M, Hirasawa K, Imai K, Okanishi T, Mizuno S, Okumura A, Sugawara M, Ito T, Ikeda H, Takahashi Y, Oguni H, Imai K, Osawa M, Yamamoto T. Liang JS, et al. Among authors: shichiji m. Epilepsia. 2011 Oct;52(10):1835-42. doi: 10.1111/j.1528-1167.2011.03174.x. Epub 2011 Jul 19. Epilepsia. 2011. PMID: 21770923 Free article.
The gross motor function measure is valid for Fukuyama congenital muscular dystrophy.
Sato T, Adachi M, Nakamura K, Zushi M, Goto K, Murakami T, Ishiguro K, Shichiji M, Saito K, Ikai T, Osawa M, Kondo I, Nagata S, Ishigaki K. Sato T, et al. Among authors: shichiji m. Neuromuscul Disord. 2017 Jan;27(1):45-49. doi: 10.1016/j.nmd.2016.09.014. Epub 2016 Sep 20. Neuromuscul Disord. 2017. PMID: 27818010
Renal dysfunction is rare in Fukuyama congenital muscular dystrophy.
Ishigaki K, Kato I, Murakami T, Sato T, Shichiji M, Ishiguro K, Ishizuka K, Funatsuka M, Saito K, Osawa M, Nagata S. Ishigaki K, et al. Among authors: shichiji m. Brain Dev. 2019 Jan;41(1):43-49. doi: 10.1016/j.braindev.2018.07.012. Epub 2018 Aug 1. Brain Dev. 2019. PMID: 30077507
Urinary titin as a biomarker in Fukuyama congenital muscular dystrophy.
Sato T, Awano H, Ishiguro K, Shichiji M, Murakami T, Shirakawa T, Matsuo M, Nagata S, Ishigaki K. Sato T, et al. Among authors: shichiji m. Neuromuscul Disord. 2021 Mar;31(3):194-197. doi: 10.1016/j.nmd.2021.01.005. Epub 2021 Jan 13. Neuromuscul Disord. 2021. PMID: 33563515
Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy.
Murakami T, Sato T, Adachi M, Ishiguro K, Shichiji M, Tachimori H, Nagata S, Ishigaki K. Murakami T, et al. Among authors: shichiji m. Sci Rep. 2021 Dec 20;11(1):24229. doi: 10.1038/s41598-021-03781-z. Sci Rep. 2021. PMID: 34930981 Free PMC article.
16 results